iThera MedicalEUPHORIA Coordinators, iThera Medical GmbH has received grant funding from the Bavarian Ministry of Economic Affairs, Regional Development and Energy to conduct a Euro 1.9 million R&D project to develop next-generation AI-supported electronics for its MSOT imaging systems for inflammatory bowel disease. The Bavarian state-funded technology innovation project, DeepOPUS, launched today, September 13th, 2021, aims to augment iThera’s proprietary optoacoustic imaging technology using AI technology, developing it into a quantitative diagnostic method for inflammatory bowel disease (IBD) and beyond. Stefan Morscher, the project leader of DeepOPUS and VP of Software Development at iThera Medical: ‘We are extremely excited to lift clinical diagnostics to a new level through the introduction of groundbreaking AI technology in an MSOT device. This will make the technology applicable to a wider patient population.’

This is an important next step to further translate the groundbreaking MSOT technology from research use to clinical routine. Read the full press release here.

The DeepOPUS project is funded through the Bavarian Ministry of Economic Affairs, Regional Development and Energy (Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie) under grant agreement No DIE-2106-0004 // DIE0161/01.